Roivant Sciences Ltd. Common Shares
$39.50
-$1.52 (-3.71%)
$39.22Day Range$41.14
Key Statistics
Market Cap
$29.63B
Shares Outstanding
722.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 1, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$41.14
Day High
$41.14
Day Low
$39.22
Volume
8.10M
VWAP
$39.66
Prev Close
$41.02
Transactions
--
Acc. Volume
--
About Roivant Sciences Ltd. Common Shares
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
PHARMACEUTICAL PREPARATIONSSIC 2834721 employees7TH FLOOR, 50 BROADWAY, LONDON, SW1H 0DB441-295-5950IPO Oct 1, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001635088
- Ticker Root
- ROIV
- SIC Code
- 2834
About Roivant Sciences Ltd. Common Shares (ROIV) Stock
Roivant Sciences Ltd. Common Shares (ROIV) closed the 2026-09-15 session at $39.50, down 3.71% versus the previous close (-1.52). The stock opened at $41.14 and traded between $39.22 and $41.14 during that session. Session trading volume was 8.1M shares. The volume-weighted average price (VWAP) is $39.66.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Roivant Sciences Ltd. Common Shares has a market capitalization of $29.63 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ROIV is listed on the XNAS exchange. The company employs approximately 721 people. The recorded listing date is 2021-10-01.
On this page you can find market ROIV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.